Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006225
Filing Date
2025-05-05
Accepted
2025-05-05 07:47:55
Documents
78
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20250331x10q.htm   iXBRL 10-Q 1369589
2 EX-10.3 ocul-20250331xex10d3.htm EX-10.3 71926
3 EX-10.4 ocul-20250331xex10d4.htm EX-10.4 76777
4 EX-10.5 ocul-20250331xex10d5.htm EX-10.5 77686
5 EX-31.1 ocul-20250331xex31d1.htm EX-31.1 11935
6 EX-31.2 ocul-20250331xex31d2.htm EX-31.2 8374
7 EX-32.1 ocul-20250331xex32d1.htm EX-32.1 4935
8 EX-32.2 ocul-20250331xex32d2.htm EX-32.2 4926
  Complete submission text file 0001558370-25-006225.txt   6452542

Data Files

Seq Description Document Type Size
9 EX-101.SCH ocul-20250331.xsd EX-101.SCH 50236
10 EX-101.CAL ocul-20250331_cal.xml EX-101.CAL 51096
11 EX-101.DEF ocul-20250331_def.xml EX-101.DEF 209486
12 EX-101.LAB ocul-20250331_lab.xml EX-101.LAB 370660
13 EX-101.PRE ocul-20250331_pre.xml EX-101.PRE 309267
81 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20250331x10q_htm.xml XML 897309
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 25910945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)